anti-HER-2 antibodies (Abiogen)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-HER-2 antibodies (Abiogen)
Drug Alias Nameanti Erbb2 monoclonal antibody (Abiogen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbiogen Pharma Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbiogen Pharma Spa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A